X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
female (44) 44
index medicus (39) 39
oncology (37) 37
breast cancer (35) 35
adult (28) 28
middle aged (28) 28
aged (22) 22
cancer (22) 22
chemotherapy (18) 18
radiotherapy (18) 18
breast neoplasms - pathology (17) 17
prognosis (16) 16
surgery (15) 15
survival (14) 14
breast neoplasms - radiotherapy (13) 13
disease-free survival (13) 13
retrospective studies (13) 13
breast neoplasms - genetics (12) 12
hematology, oncology and palliative medicine (12) 12
care and treatment (11) 11
metastasis (11) 11
radiology, nuclear medicine & medical imaging (11) 11
recurrence (11) 11
treatment outcome (11) 11
tumors (11) 11
breast neoplasms - drug therapy (10) 10
breast neoplasms - mortality (10) 10
follow-up studies (10) 10
male (10) 10
metastases (10) 10
patients (10) 10
breast neoplasms - surgery (9) 9
medical prognosis (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoma (8) 8
medicine (8) 8
radiation-therapy (8) 8
research (8) 8
risk factors (8) 8
aged, 80 and over (7) 7
breast neoplasms - metabolism (7) 7
cancer patients (7) 7
multivariate analysis (7) 7
neoadjuvant chemotherapy (7) 7
neoplasm staging (7) 7
proportional hazards models (7) 7
cancer therapies (6) 6
child (6) 6
child, preschool (6) 6
drug therapy (6) 6
france (6) 6
lymph nodes (6) 6
mastectomy, segmental (6) 6
medicine & public health (6) 6
neoadjuvant therapy (6) 6
prospective studies (6) 6
radiation therapy (6) 6
radiology and nuclear medicine (6) 6
survival rate (6) 6
therapy (6) 6
toxicity (6) 6
trastuzumab (6) 6
biomarkers, tumor - metabolism (5) 5
breast (5) 5
breast neoplasms - therapy (5) 5
carcinoma, ductal, breast - pathology (5) 5
cohort studies (5) 5
diagnosis (5) 5
gene expression (5) 5
genetic aspects (5) 5
immunohistochemistry (5) 5
infant (5) 5
kaplan-meier estimate (5) 5
lumpectomy (5) 5
lymphatic system (5) 5
mammary glands (5) 5
multidisciplinary sciences (5) 5
neoplasm recurrence, local - pathology (5) 5
neoplasms (5) 5
oncology, experimental (5) 5
pathology (5) 5
pregnancy (5) 5
proliferation (5) 5
radiology (5) 5
research article (5) 5
young adult (5) 5
adjuvant treatment (4) 4
adolescent (4) 4
age (4) 4
age factors (4) 4
biopsy (4) 4
breast-conserving treatment (4) 4
carcinoma, ductal, breast - drug therapy (4) 4
carcinoma, ductal, breast - radiotherapy (4) 4
carcinomas (4) 4
cell proliferation (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
epidemiology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 03/2018, Volume 118, Issue 6
This corrects the article DOI: 10.1038/bjc.2017.85 
ONCOLOGY | ErbB-2 protein | Chemotherapy | Trastuzumab
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 11, pp. 1458 - 1463
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2010, Volume 122, Issue 2, pp. 429 - 437
To assess anti-tumor activity of sequential epirubicin/cyclophosphamide followed by docetaxel with the randomized addition of celecoxib in HER2 negative... 
Neoadjuvant chemotherapy | Oncology | Breast cancer | Celecoxib | Medicine & Public Health | Trastuzumab | SURGICAL ADJUVANT BREAST | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | STAGE-II | PACLITAXEL | TRIAL | PRIMARY SYSTEMIC THERAPY | PREOPERATIVE CHEMOTHERAPY | EPIRUBICIN | ONCOLOGY | COX-2 INHIBITORS | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Antibodies, Monoclonal, Humanized | Time Factors | Adult | Female | Neoadjuvant Therapy | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | France | Neoplasm Invasiveness | In Situ Hybridization, Fluorescence | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Pyrazoles - administration & dosage | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Therapeutics | Neoplasm Staging | Sulfonamides - administration & dosage | Lumpectomy | Care and treatment | Cancer patients | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Angiogenesis inhibitors | Cancer | Antimitotic agents | Chemotherapy | Antineoplastic agents | Index Medicus
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2010, Volume 120, Issue 1, pp. 119 - 126
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0144359
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e14135 - e14135
Journal Article
CANCERS, ISSN 2072-6694, 06/2019, Volume 11, Issue 6, p. 863
Patients with liver metastases of uveal melanoma (LMUM) die from their metastatic evolution within 2 years. We established a nomogram to choose a treatment... 
SURVIVAL | liver metastasis | tumour burden | liver MRI | ONCOLOGY | RESECTION | uveal melanoma | DISEASE | prognostic factors | OPTIONS | Nuclear magnetic resonance--NMR | Decision making | Liver | Melanoma | Clinical trials | Oncology | Metastasis | Patients | L-Lactate dehydrogenase | Metastases | Studies | Magnetic resonance imaging | Life span | Medical prognosis | Lactic acid | Clinical medicine | Cancer | Tumors
Journal Article
The Breast Journal, ISSN 1075-122X, 11/2017, Volume 23, Issue 6, pp. 687 - 693
Journal Article
BMC Medical Research Methodology, ISSN 1471-2288, 06/2014, Volume 14, Issue 1, pp. 83 - 83
Background: Paired survival data are often used in clinical research to assess the prognostic effect of an exposure. Matching generates correlated censored... 
Marginal Cox model | Pregnancy | Simulation study | Matching on time-dependent covariates | Stratified Cox model | Breast cancer |